Characterization of chromatin modified with reactive oxygen species: Recognition by autoantibodies in cancer

Greater recognition of ROS-modified chromatin with the autoantibodies in cancer sera is indicative of reactive-oxygen-species-induced chromatin damage in cancer patients.